Termini

CodeSystemsConceptSystemsStructureDefinitionsValueSetsPackagesConflicts
StructureDefinitionsMedicinalProductPharmaceutical

http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1

A pharmaceutical product described in terms of its composition and dose form.
StructureJSONDependenciesFHIRSchemaOther VersionsDependant (0)ElementsSummary
NameFlagsCardTypeDescription & Constraints
MedicinalProductPharmaceutical
0..*A pharmaceutical product described in terms of its composition and dose form
 
identifier
Σ
0..*IdentifierAn identifier for the pharmaceutical medicinal product
 
administrableDoseForm *
Σ
1..1CodeableConceptThe administrable dose form, after necessary reconstitution
 
unitOfPresentation
Σ
0..1CodeableConceptTodo
 
ingredient
Σ
0..*ReferenceIngredient
 
device
Σ
0..*ReferenceAccompanying device
 
characteristics
Σ
0..*BackboneElementCharacteristics e.g. a products onset of action
 
 
code *
Σ
1..1CodeableConceptA coded characteristic
 
 
status
Σ
0..1CodeableConceptThe status of characteristic e.g. assigned or pending
 
routeOfAdministration *
Σ
1..*BackboneElementThe path by which the pharmaceutical product is taken into or makes contact with the body
 
 
code *
Σ
1..1CodeableConceptCoded expression for the route
 
 
firstDose
Σ
0..1QuantityThe first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
 
 
maxSingleDose
Σ
0..1QuantityThe maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
 
 
maxDosePerDay
Σ
0..1QuantityThe maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
 
 
maxDosePerTreatmentPeriod
Σ
0..1RatioThe maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
 
 
maxTreatmentPeriod
Σ
0..1DurationThe maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
 
 
targetSpecies
Σ
0..*BackboneElementA species for which this route applies
 
 
 
code *
Σ
1..1CodeableConceptCoded expression for the species
 
 
 
withdrawalPeriod
Σ
0..*BackboneElementA species specific time during which consumption of animal product is not appropriate
 
 
 
 
tissue *
Σ
1..1CodeableConceptCoded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
 
 
 
 
value *
Σ
1..1QuantityA value for the time
 
 
 
 
supportingInformation
Σ
0..1stringExtra information about the withdrawal period